Business · 21/09/2017Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting of Dermatologic and Ophthalmic Drugs Advisory Committee
Summary
The FDA is hosting a public meeting of its Dermatologic and Ophthalmic Drugs Advisory Committee to gather input on regulatory issues, with a public docket open for comments.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →